OverviewSuggest Edit

Grail is a healthcare company engaged in cancer detection. It uses high-intensity sequencing, population-scale clinical studies, computer science and data science to develop products for the detection of cancer at a curable stage.
TypePrivate
Founded2016
HQMenlo Park, CA, US
Websitegrail.com
Overall CultureA-

Latest Updates

Employees (est.) (Feb 2021)531(+5%)
Cybersecurity ratingBMore

Key People/Management at Grail

Bill Rastetter

Bill Rastetter

Director
Hans Bishop

Hans Bishop

Chief Executive Officer, Director
Satnam Alag

Satnam Alag

Senior Vice President, Software Engineering
Gautam Kollu

Gautam Kollu

Chief Commercial Officer
Nathan Hunkapiller

Nathan Hunkapiller

Vice President, Research and Development
Alice Chen

Alice Chen

Vice President, Product and Head of Program Management Organization
Show more

Grail Office Locations

Grail has an office in Menlo Park
Menlo Park, CA, US (HQ)
1525 O'Brien Dr
Show all (1)

Grail Financials and Metrics

Summary Metrics

Founding Date

2016

Grail total Funding

$2 b

Grail latest funding size

$390 m

Time since last funding

10 months ago

Grail investors

Grail's latest funding round in May 2020 was reported to be $390 m. In total, Grail has raised $2 b
Show all financial metrics

Grail Cybersecurity Score

Cybersecurity ratingPremium dataset

B

86/100

SecurityScorecard logo

Grail Online and Social Media Presence

Embed Graph

Grail Company Culture

  • Overall Culture

    A-

    86/100

  • CEO Rating

    A-

    80/100

  • Compensation

    A+

    100/100

Learn more on Comparably

Grail Blogs

GRAIL Appoints Sir Harpal Kumar as President of GRAIL Europe

MENLO PARK, Calif., April 10, 2020 — GRAIL, Inc., a healthcare company whose mission is … The post GRAIL Appoints Sir Harpal Kumar as President of GRAIL Europe appeared first on GRAIL.

GRAIL Announces Validation of its Multi-Cancer Early Detection Test Published in Annals of Oncology

— CCGA Results Demonstrate Robust Validity of GRAIL’s Multi-Cancer Early Detection Approach — — Data … The post GRAIL Announces Validation of its Multi-Cancer Early Detection Test Published in Annals of Oncology appeared first on GRAIL.

Fact Sheet: The Circulating Cell-free Genome Atlas (CCGA) Study

Developing a single blood test for the early detection of multiple deadly cancer types is … The post Fact Sheet: The Circulating Cell-free Genome Atlas (CCGA) Study appeared first on GRAIL.

GRAIL Initiates First Interventional Study Using its Multi-Cancer Early Detection Test to Guide Clinical Care

–The PATHFINDER Study will Return GRAIL’s Test Results to Providers for the First Time — … The post GRAIL Initiates First Interventional Study Using its Multi-Cancer Early Detection Test to Guide Clinical Care appeared first on GRAIL.

GRAIL Appoints Gautam Kollu as Chief Commercial Officer

MENLO PARK, Calif., December 16, 2019 – GRAIL, Inc., a healthcare company whose mission is … The post GRAIL Appoints Gautam Kollu as Chief Commercial Officer appeared first on GRAIL.

Working to Transform Cancer Care Through Early Detection

Josh Ofman, MD, MSHS, Chief of Corporate Strategy and External Affairs Biomedical innovation is occurring … The post Working to Transform Cancer Care Through Early Detection appeared first on GRAIL.
Show more

Grail Frequently Asked Questions

  • When was Grail founded?

    Grail was founded in 2016.

  • Who are Grail key executives?

    Grail's key executives are Bill Rastetter, Hans Bishop and Satnam Alag.

  • How many employees does Grail have?

    Grail has 531 employees.

  • Who are Grail competitors?

    Competitors of Grail include NeoTX, OncoOne and Elypta.

  • Where is Grail headquarters?

    Grail headquarters is located at 1525 O'Brien Dr, Menlo Park.

  • Where are Grail offices?

    Grail has an office in Menlo Park.

  • How many offices does Grail have?

    Grail has 1 office.